2018 Pan Pacific Lymphoma Conference

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

2018 Pan Pacific Lymphoma Conference

Bench to Bedside
Novel Therapies in Lymphoma
High Grade B-cell Lymphoma
Aggressive T-Cell Lymphoma
Hodgkin Lymphoma
Multiple Myeloma/Plasma Cell Dyscrasia
Common Indolent Lymphoma
Uncommon Indolent Lymphoma
Interprofessional Educational Day

Playback speed

10 seconds

Evalutation of patients for ASCT in Relapsed Refractory Hodgkin Lymphoma

By 2018 Pan Pacific Lymphoma Conference FEATURING Craig Moskowitz

0 views

August 15, 2018

Comments 0

Evaluation, Diagnosis, Prognostication, and Emerging Therapies for M…

Feat. A. Tefferi

Treatment Strategies for Hematocrit Control in PV

Feat. A. Zhou

Hodgkin Lymphoma

20:26

2018 Pan Pacific Lymphoma Conference

Radiation Therapy for nondular lymphocyte predominant Hodgkin Lympho…

Feat. R. Hoppe

10:00

2018 Pan Pacific Lymphoma Conference

Relapsed and Primary Refractory Hodgkin Lymphoma in the Near Future

Feat. C. Moskowitz

15:48

2018 Pan Pacific Lymphoma Conference

Evalutation of patients for ASCT in Relapsed Refractory Hodgkin Lymp…

Feat. C. Moskowitz

21:11

2018 Pan Pacific Lymphoma Conference

Use of Total Metabolic Tumor Volume in PET Scans

Feat. N. Hansen

06:45

2018 Pan Pacific Lymphoma Conference

Hodgkin Lymphoma: First Relapse Options

Feat. B. Pro

16:04

2018 Pan Pacific Lymphoma Conference

Beyond Standard Chemotherapy Novel Agents and Appraoches in HL

Feat. B. Pro

20:54

2018 Pan Pacific Lymphoma Conference

Beyond Checkpoint Inhibitors for Hodgkin Lymphoma

Feat. S. Ansell

14:48

2018 Pan Pacific Lymphoma Conference

Hodgkin Lymphoma German Hodgkin Study Group Upfront Therapy

Feat. A. Engert